3-hydroxykynurenine has been researched along with Vascular Diseases in 1 studies
3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, LV | 1 |
| Minović, I | 1 |
| Franssen, CFM | 1 |
| van Faassen, M | 1 |
| Sanders, JS | 1 |
| Berger, SP | 1 |
| Navis, G | 1 |
| Kema, IP | 1 |
| Bakker, SJL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| TransplantLines Insulin Resistance and Inflammation Biobank and Cohort Study[NCT03272854] | 606 participants (Actual) | Observational [Patient Registry] | 2001-08-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for 3-hydroxykynurenine and Vascular Diseases
| Article | Year |
|---|---|
The tryptophan/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation.
Topics: Adult; Biomarkers; Chromatography, Liquid; Female; Graft Rejection; Graft Survival; Humans; Inflamma | 2017 |